Mechanical Thrombectomy in Pulmonary Embolism
Mechanical thrombectomy is indicated in pulmonary embolism when patients have high-risk (massive) PE with contraindications to thrombolysis or when thrombolytic therapy has failed. 1
Primary Indications
High-Risk (Massive) PE
- Patients with hemodynamic instability (shock and/or persistent hypotension) 1
- When thrombolysis is contraindicated or has failed 1
- When shock is likely to cause death before systemic thrombolysis can take effect (within hours) 1
Contraindications to Thrombolysis
Common contraindications that may necessitate mechanical thrombectomy include:
- Recent hemorrhagic stroke 1
- Ischemic stroke within preceding 6 months 1
- Central nervous system damage or neoplasms 2
- Recent major trauma/surgery/head injury (within preceding 3 weeks) 2
- Active gastrointestinal bleeding 1
- Advanced liver disease 1
Patient Selection Criteria
Anatomical Considerations
- Optimal candidates have thrombus in the main pulmonary artery or major branches 1
- Patients without fixed pulmonary hypertension (which suggests chronic thromboembolic disease) 1
- Central thrombus propagation despite anticoagulation 1
- Risk of limb loss (e.g., phlegmasia cerulea dolens) 1
Clinical Considerations
- Patients deemed high risk for surgical thrombectomy 3
- Moderate to severely symptomatic proximal DVT 1
- Patients with right ventricular dysfunction and elevated cardiac biomarkers who show clinical deterioration on anticoagulation 1
Procedural Approaches
Catheter-Directed Techniques
- Aspiration mechanical thrombectomy using large-bore catheters 2, 4
- Pharmacomechanical thrombectomy (combining mechanical disruption with local thrombolytic agents) 1
- Conservative approach (early termination once hemodynamic parameters improve) may reduce complication rates 3
Surgical Embolectomy Considerations
- Surgical embolectomy should be considered when catheter-based interventions are not available or feasible 1
- Requires median sternotomy with cardiopulmonary bypass 1
- Higher mortality rates (20-50%) but may be life-saving in appropriate candidates 1
Expected Outcomes
Hemodynamic Improvements
- Increase in systemic arterial pressure 3
- Decrease in heart rate 3
- Reduction in pulmonary artery systolic pressure 4
- Improvement in right ventricular size and function 3, 4
Clinical Benefits
- Reduced right ventricular/left ventricular ratio 4
- Improved pulmonary oxygen saturation 2
- Decreased Miller index (measure of pulmonary vascular obstruction) 2, 4
Cautions and Considerations
Procedural Risks
- Bleeding complications (estimated blood loss 200-450cc) 5
- Need for blood transfusions in some patients 5
- Local damage to venous access site 1
- Potential for cardiac perforation or tamponade 1
Institutional Factors
- Should only be performed at centers with appropriate expertise and resources 1
- Requires collaboration between interventional radiology or vascular surgery colleagues 1
- Decision should be made on a case-by-case basis 1
Follow-up Considerations
- Monitor for recurrent PE 2
- Assess for development of pulmonary hypertension 2
- Continue appropriate anticoagulation therapy post-procedure 1
- Consider IVC filter placement in select patients with contraindications to anticoagulation 1
Mechanical thrombectomy represents an important treatment option for patients with high-risk PE who cannot receive thrombolysis or who have failed thrombolytic therapy, with evidence showing improvements in hemodynamic parameters and right ventricular function when performed at experienced centers.